Powered by Ajaxy


Cyberwarfare: Assessing 21st-Century Security Threats

By David Dittman - Oct 20, 2016

Warfare in the 21st century is fought on land, at sea, and in the air. It’s also contested in cyberspace.


How Do We Fight the “Forever War”?

By David Dittman - Oct 6, 2016

The United States has been at war almost continuously since its founding 240 years ago. There’s no reason to expect anything but more of the same.


Genetically Optimized vs. Genetically Modified Organisms

By David Dittman - Sep 27, 2016

Will Monsanto weaponize the highly advanced gene-editing technology it’s just licensed? Or are its purposes, as they say, entirely benevolent?


There’s Gold in Them Thar Spacecraft

By David Dittman - Sep 22, 2016

Gold is well-known for protecting investors and their portfolios. But it can do so much more. Like protect astronauts and their spacecraft.

Food & Beverage

Restaurant Stocks: Why These Investments Boast “100-Bagger” Potential

By Wall Street Daily Research - Sep 20, 2016

While many restaurant companies are enduring a tough time right now, their economics are still sound — and their stocks offer truly outstanding investment potential.


How to Become a Millionaire… Using Other People’s Money

By Wall Street Daily Research - Sep 19, 2016

We bring you the story of Rankin Hodgins – a simple man from humble beginnings who managed to turn $200,000 into $6.6 million… without ever adding to his account.


Sun Hydraulics: Shattering the Morass of Middle Management

By David Dittman - Sep 15, 2016

It’s time to end the mediocre middle-management structure and put that manpower to work in more valuable positions. One company is on the right track…


Surveillance: Your iPhone Is Stalking You

By David Dittman - Sep 14, 2016

Think “Big Brother” is a new phenomenon? It’s not. We’re being watched, and we have been for centuries. And thanks to our mobile-based “always on, always connected” society, we’re only making it easier to be tracked.

Healthcare Technology

Theranos: The Rise and Fall of an Empire of Lies

By David Dittman - Sep 9, 2016

We recount the story of Theranos. A blood-testing technology that was “full of holes,” yet still managed to acquire a $9 billion valuation – and why that has up on guard about the new “smoke detector for cancer.”


Small-Cap Utility Stocks: No Flash… All Cash

By David Dittman - Aug 24, 2016

Traditionally, small-cap stocks are associated with growth, not value. But focus on this area of the small-cap market and you can build wealth safely over the long term.

Global Warming

The Global War on Global Warming

By David Dittman - Aug 17, 2016

The mobilization for World War II drove rapid economic growth, a rise in employment and higher productivity and corporate profits in the U.S. Could a war on global warming yield the same opportunities?

Small Caps

Babe Ruth Has Nothing on Lou Basenese

By David Dittman - Aug 12, 2016

Babe Ruth’s “called shot” gesture was ambiguous. There’s no question Lou Basenese predicted the recent small-cap rally.